AzTrials
AzTrials

Healthy Adult Male and Female VolunteersReHIIT_CONNCT07313332

Exploring Resistance Exercise Training Plus High-Intensity Interval Training (ReHIIT) as Cancer Prehabilitation

A study testing ReHIIT Training Intervention in people with Healthy Adult Male and Female Volunteers and Intervention, run by University of Nottingham at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Colorectal cancer is the fourth most common cancer in the UK. Prehabilitation, including exercise, can improve recovery from surgery. This pilot study investigates the combined effects of resistance and high-intensity interval training (ReHIIT) in healthy adults to establish baseline physiology and responses for… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
ReHIIT Training Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteUnited Kingdom
Study dates
1 Jan 2026to 1 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participant is willing and able to give informed consent for participation in the study.
  • Availability and willingness to attend the Royal Derby Hospital site for a minimum of 8 exercise sessions and 2 assessment sessions across the study period.

Who cannot join

  • BMI <18 or >35 kg/m2
  • Known active cance
  • Known metabolic disease
  • Current known neurological or musculoskeletal conditions (e.g. epilepsy)
  • Active known cardiovascular, cerebrovascular or respiratory disease - e.g:
  • Uncontrolled hypertension (systolic BP > 160 mmHg or diastolic BP >100 mmhg)
Show all 21Show fewer
  • Myocardial infarction within the last 6 months or unstable angina
  • Heart failure (New York Heart association Class III/IV)
  • Arrhythmia
  • Right to left cardiac shunt
  • Aneurysm of a named blood vessel
  • COPD
  • Pulmonary hypertension
  • Exercise-induced or brittle asthma
  • Previous stroke/transient ischaemic attack
  • Abnormal ECG results (at the discrepancy of the study doctor)
  • Patients who are unable to undergo CPET based on ATS/ACSS guidelines ^
  • Pre-existing clotting disorder known to the participant or anticoagulant use
  • Family history of severe bleeding requiring medical intervention
  • Participation in a research study in the last 3 months involving invasive procedures or an inconvenience allowance (ALL UoN FMHS UREC approved studies)
  • Pregnant or breastfeeding

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Tyler J Daubrah-Scott, MRes, BSc (Hons) contact

01332 724676

tyler.daubrah-scott@nottingham.ac.uk

Wayne Fradley, BMBS (hons) MRCS (2022) contact

01332 724640

wayne.fradley@nottingham.ac.uk

United Kingdom1 site, 1 recruiting
  • Medical School, University of Nottingham, Royal Derby Hospital

    Derby, Derbyshire, DE223DT

    Recruiting

Other trials in United Kingdom

About this study

Official title: Exploring Resistance Exercise Training Plus High-Intensity Interval Training (ReHIIT) as Cancer Prehabilitation: A Healthy Control Group Pilot Study

Colorectal cancer is the fourth most common cancer in the UK. Prehabilitation, including exercise, can improve recovery from surgery. This pilot study investigates the combined effects of resistance and high-intensity interval training (ReHIIT) in healthy adults to establish baseline physiology and responses for comparison with cancer patients

Read the detailed description

Colorectal cancers are a leading cause of death in the UK, but many can be cured with surgery alone. From diagnosis to surgery or alternative first treatment, the UK government mandates a maximum timeline of 31 days, providing only a short window in which patients may be physically optimised by exercise before surgery. There is increasing interest in clinical and academic settings regarding the potential benefits of exercise-based surgical prehabilitation. Although surgery is often successful, the combined effects of cancer and surgical stress can lead to poor clinical and patient-centred outcomes, including delayed return to normal activities and reduced quality of life. Physiological parameters known to be improved through exercise training, such as cardiorespiratory fitness and muscle mass, have been associated with more favourable clinical outcomes for individuals undergoing colorectal cancer surgery, including anaesthetic risk and tolerance to adjuvant treatment.

The limited time available before surgery remains a major challenge. Traditional modes of exercise training, including aerobic and resistance exercise performed separately, typically require six weeks or more to produce meaningful improvements in their primary physiological adaptations. As a result, recent cancer rehabilitation research has increasingly used high-intensity interval training (HIIT) because it requires less time and has been shown to improve both cardiorespiratory fitness and muscle mass more rapidly than traditional exercise modalities.

Although HIIT has demonstrated potential in several patient groups, previous work has shown that individuals with colorectal cancer may not experience improvements in cardiorespiratory fitness or muscle mass after a four-week HIIT intervention, even though the same protocol has produced adaptations in older adults and individuals with other cancer types. This may reflect a degree of anabolic or physiological resistance in the colorectal cancer population. Based on this, a current trial is comparing HIIT alone with a combined approach of HIIT plus resistance exercise training (ReHIIT) to determine whether the addition of resistance exercise can overcome this reduced adaptive response.

However, the expected magnitude of physiological adaptation to four weeks of ReHIIT in adults without cancer has not been fully characterised. This study will therefore explore changes in cardiorespiratory fitness, muscle mass, and associated metabolic and molecular mechanisms in healthy adults following a four-week ReHIIT programme.

Being tested
ReHIIT Training Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReHIIT Training InterventionOther

    Participants will complete 8-12 supervised sessions combining high-intensity interval cycling (5 × 1-minute intervals at 110% CPET wattage, with 90-second rest intervals) and resistance training at 70% 1-RM (3 sets of 8-12 repetitions, 6 exercises).

Study groups in NCT07313332
Study groupRoleWhat they receive
Resistance exercise training plus high-intensity interval training (ReHIIT) InterventionExperimentalParticipants will complete 8-12 supervised sessions combining high-intensity interval cycling and resistance training at 70% 1-RM.
Receives: Other: ReHIIT Training Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in anaerobic threshold (CPET-derived)

    Measured: From baseline to 4-weeks after the start of the intervention

  2. Change in Muscle mass

    Derived from DXA and stable isotope assessments of muscle mass (COSIAM, Cegielski et al., 2021)

    Measured: From baseline to 4-weeks after the start of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2025
  2. Study start1 Jan 2026
  3. Primary completion1 Dec 2027 (estimated)
  4. Study completion1 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
Participants will complete 8-12 supervised sessions combining high-intensity interval cycling and resistance training (three sets of 8 reps @ \~70% 1-RM across 6 exercises (3 upper-body, 3 lower-body)).
Masking
None (open label)
Enrolment
14 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07313332
Sponsor's protocol ID
FMHS 237-0925
Acronym
ReHIIT_CON
Status last verified
Oct 2025
First submitted
28 Nov 2025
Last updated
14 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ReHIIT Training Intervention in people with Healthy Adult Male and Female Volunteers and Intervention, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 21 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tyler J Daubrah-Scott, MRes, BSc (Hons) (01332 724676, tyler.daubrah-scott@nottingham.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in anaerobic threshold (CPET-derived) (time frame: From baseline to 4-weeks after the start of the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in